35 min ago
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Signing Of Rights Agreement With
The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01 combination product that ViaCyte is developing for type 1 diabetes.
4 hrs ago
Dow Movers: BA, JNJ
Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.
9 hrs ago
Jeff Reeves's Strength in Numbers: This one stock sector can withstand all the 'bubble' talk
A beleaguered Johnson & Johnson has rebounded since January 2013, with its stock jumping 50% to beat the S&P 500.
12 hrs ago
Illumina Partners With Big PharmaTo Create New Genetic Tests For Cancer
I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today.
Tue Aug 19, 2014
Apple Inc. (AAPL), American Express Company (AXP), Johnson & Johnson...
Ken Fisher 's Fisher Asset Management filed a few weeks ago its Form 13F for the second quarter of 2014.
The Motley Fool
3 Reasons Hospira, Inc. Stock Could Rise
Last quarter, the maker of specialty injectable pharmaceuticals and medical devices reported that its revenue rose 11% year-over-year to $1.1 billion, while its adjusted earnings per share rose 31% to $0.72 per share.
Mon Aug 18, 2014
2 U.S. IPOs Planned For The Week Of August 18
Only two IPOs are expected to begin trading this week, both holdovers from last week that had originally been on the calendar for the week of August 4. The IPO market has begun its annual late-August hiatus, as last week's two deals trade just 1% from the IPO price and none are expected for next week.
TTIP: From Hot Tip to Oblivion?
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.
Apple Inc. (AAPL), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Among...
AQR Capital Management , managed by Cliff Asness , recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.
Product Defect News
Have You Been Injured By A Defective Hip Implant?
When your car is a lemon or is recalled for safety issues, you get it fixed at no cost at the dealership.
Interesting April 2015 Stock Options for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .
The NOW Project 2014 update - a future proofing segmentation tool
The NOW Project is a unique segmentation that delivers insights into the hearts and minds of the people of RSA, enabling marketers to read change and position brands with a future facing perspective.
Sun Aug 17, 2014
5 brands that climbed out of reputation hell
For a brand, recovering its reputation after a crisis can be a complicated business.
Sat Aug 16, 2014
The Jersey Journal
Local artist to have showcase at Bunnvale Library
Works by Doris Terris, of Lebanon Township, will be on display at the Bunnvale Library, Rte 513 Lebanon Township for the month of September.
Fri Aug 15, 2014
Diabetes Self Management
New Metformin Combo Drug Approved for Type 2 Diabetes
On August 8, the U.S. Food and Drug Administration approved the oral combination medicine canagliflozin/metformin for Type 2 diabetes .
National Institute for Clinical Excellence (NICE) And Johnson & Johnson Urged To End Zytiga Fiasco
Patient groups and academics have urged the National Institute for Health and Care Excellence and Johnson & Johnson unit Janssen to get back to the table following the former's rejection of Zytiga as a treatment for prostate cancer before chemotherapy.
Thu Aug 14, 2014
Johnson & Johnson: Don't Miss The Pullback Opportunity
JNJ can comfortably grow its dividend per share by 6%-7% per annum over the next few years with both free cash flow and earnings payout levels being steady.
Wed Aug 13, 2014
Check Your Mental Health With Just A Press Of A Button
Philadelphia residents can now check their mental health in the grocery store, thanks to an interactive screening kiosk known as "Checkup and Checkout" that officials unveiled earlier this month.
Why I Ignored My Own Advice And Bought Johnson & Johnson Sans Pullback
In my opinion, Johnson & Johnson is an attractive investment given its vibrant growth and 51 consecutive years of dividend increases.
Tue Aug 12, 2014
Harvard Business School
First Look: August 12
First Look summarizes new working papers, case studies, and publications produced by Harvard Business School faculty.